Turnstone Biologics Corp.
TSBX
$0.35
$0.0319.72%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -70.84M | -74.42M | -74.70M | -74.90M | -55.20M |
| Total Depreciation and Amortization | 1.84M | 2.16M | 2.37M | 2.60M | 2.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.52M | 1.24M | 2.50M | 3.15M | 4.17M |
| Change in Net Operating Assets | 47.00K | 4.55M | 2.16M | 2.71M | -17.92M |
| Cash from Operations | -67.44M | -66.47M | -67.68M | -66.44M | -66.15M |
| Capital Expenditure | -229.00K | -248.00K | -508.00K | -513.00K | -1.25M |
| Sale of Property, Plant, and Equipment | 25.00K | 297.00K | 284.00K | 322.00K | 452.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 78.76M | 51.93M | -14.31M | -30.31M | -27.30M |
| Cash from Investing | 78.56M | 51.98M | -14.53M | -30.50M | -28.09M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 44.00K | 44.00K | 78.07M | 78.03M | 78.11M |
| Repurchase of Common Stock | -- | -169.00K | -169.00K | -169.00K | -169.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -33.00K | -33.00K | 177.00K | 0.00 | -898.00K |
| Cash from Financing | 11.00K | -158.00K | 78.08M | 77.86M | 77.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.13M | -14.64M | -4.13M | -19.08M | -17.20M |